Hemostemix (TSE:HEM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Hemostemix Inc. successfully concluded its private placement, raising a total of $2,675,981 to advance its stem cell therapeutics platform. The proceeds will be used for product development, sales initiation, and general operations, highlighting the company’s commitment to its innovative medical solutions.
For further insights into TSE:HEM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue